Sabra Health Care REIT, Inc.
SBRANasdaqCIK 1492298Real estateFiscal year ends Dec 31
Reports and events: 330 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0316:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001492298-26-000028 |
| 2026-08-0316:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000027 |
| 2026-07-2109:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000023 |
| 2026-06-1716:40 ET | 8-K | 5.07 Shareholder vote results | 0001492298-26-000019 |
| 2026-05-2816:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000014 |
| 2026-04-2916:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001492298-26-000012 |
| 2026-04-2916:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000011 |
| 2026-04-2409:06 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001193125-26-175398 |
| 2026-02-1216:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001492298-26-000008 |
| 2026-02-1216:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000007 |
| 2026-01-0509:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-26-000002 |
| 2025-11-0516:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001492298-25-000039 |
| 2025-11-0516:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000038 |
| 2025-08-0517:16 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-173630 |
| 2025-08-0416:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001492298-25-000031 |
| 2025-08-0416:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000030 |
| 2025-07-3116:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001492298-25-000027 |
| 2025-06-3016:05 ET | 8-K | 8.01 Other events | 0001492298-25-000025 |
| 2025-06-1216:18 ET | 8-K | 5.07 Shareholder vote results | 0001492298-25-000018 |
| 2025-05-0516:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001492298-25-000016 |
| 2025-05-0516:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000015 |
| 2025-04-2509:00 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001193125-25-095172 |
| 2025-03-2409:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000011 |
| 2025-02-1916:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001492298-25-000008 |
| 2025-02-1916:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-25-000007 |
| 2024-11-1209:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001492298-24-000033 |
| 2024-10-3116:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001492298-24-000031 |
| 2024-10-3116:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000030 |
| 2024-08-0716:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001492298-24-000025 |
| 2024-08-0716:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000024 |
| 2024-06-1317:20 ET | 8-K | 5.07 Shareholder vote results | 0001492298-24-000017 |
| 2024-05-0816:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001492298-24-000014 |
| 2024-05-0816:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000013 |
| 2024-04-2609:01 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001193125-24-116049 |
| 2024-02-2716:08 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001492298-24-000008 |
| 2024-02-2716:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000007 |
| 2024-01-0409:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-24-000003 |
| 2023-11-0616:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001492298-23-000025 |
| 2023-11-0616:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000024 |
| 2023-08-0716:07 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001492298-23-000021 |
| 2023-08-0716:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000020 |
| 2023-06-1416:45 ET | 8-K | 5.07 Shareholder vote results | 0001492298-23-000016 |
| 2023-05-0316:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001492298-23-000014 |
| 2023-05-0316:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000013 |
| 2023-04-2409:03 ET | DEF 14A | Proxy statement | 0001193125-23-111909 |
| 2023-03-2016:05 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001492298-23-000008 |
| 2023-02-2309:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-045742 |
| 2023-02-2116:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001492298-23-000006 |
| 2023-02-2116:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001492298-23-000005 |
| 2023-01-0509:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-002031 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.